Twist Bio (TWST) Total Business Assets

This chart of the market valuation of Twist Bioscience (TWST) total assets, which stands at 657.94, illustrates business development based on silicon-based DNA synthesis and innovative information storage. Twist Bioscience (TWST) is betting on organic resource expansion and tight integration with industry behemoths for antibody creation. Revenue is generated through B2B supplies of genetic material for the agricultural sector, research institutes, and vaccine developers.

Assessing total resources through a reverse ROA calculation allows for the determination of Twist Bioscience (TWST) real business resilience by combining equity and liabilities. The growth in gross assets confirms the expansion of the base for the commercialization of silicon-based DNA synthesis and archival data storage, which is critical when scaling high-margin R&D partnerships amid rising demand from the pharmaceutical industry.